Navigation Links
Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
Date:11/7/2013

from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. The Company's financial results for the quarter ended September 30, 2013 may not necessarily be indicative of future results. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2012, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link: 
http://www.pressurebiosciences.com 
Please visit us on: Facebook, LinkedIn, and Twitter. 

 PRESSURE BIOSCIENCES, INC. AND SUBSIDIARYCONDENSED CONSOLIDATED BALANCE SHEETSSeptember 30,December 31,ASSETS20132012(Unaudited)(Audited)CURRENT ASSETSCash and cash equivalents

$66,680$1,461Accounts receivable

200,914216,265Inventories, net of $50,000 reserve at September 30, 2
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
2. Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019: Transparency Market Research
3. Hazardous, High-Pressure and Explosive Conditions Are No Match for Swiss Jewel Sapphire Windows
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
5. China Medical Flat Panel Detector Market & Pressure Injector 2013 Research Reports Now Available at ReportsnReports.com
6. Using pressure to swell pores, not crush them
7. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
8. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
9. High pressure gold nanocrystal structure revealed
10. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
11. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... What: , Cambridge Semantics, the leading provider of ... today announced its participation in the 2014 Big Data ... solutions provide semantic linkage and meaning to Big Data ... manage diverse data. Ben Szekely, vice president and founding ... “life sciences data lake” and an approach for collecting ...
(Date:10/1/2014)... Greifensee, Switzerland (PRWEB) October 01, 2014 ... influence the quality of the final product. However, ... most regulated, regulatory frameworks such as Good Manufacturing ... is the responsibility of the manufacturer to interpret ... ensure consistent weighing performance quality. METTLER TOLEDO experts ...
(Date:10/1/2014)... 30, 2014 The participants committed to ... to spending their own time adjusting, tweaking and testing ... designs were ready for judging. , “I enjoyed being ... thought leader. “The entries showed a commendable range ... characteristics of the print medium and the creativity of ...
(Date:10/1/2014)... Award winning unified communications (UC) ... new-hosted collaboration bundles that combine next generation communication ... experiences for low, flat rate fees. With ... have optimized solutions to meet their technology needs. ... only minutes (1K, 5K, 10K increments) or audio ...
Breaking Biology Technology:Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2Comply with Weighing-Related Regulations in Pharma Manufacturing 2Array Architects Challenges Staff to Create with 3D Printer 2SoundConnect Launches New Audio, Web and Video Bundles 2
... Oct. 16 Compendia Bioscience, Inc.,today announced ... Premium Edition, a high-value product extension of ... Oncomine Research,Premium Edition includes custom gene filters, ... support for Oncomine Concepts Map,including the ability ...
... DRRX ) announced today that it will be hosting ... at 12:00 p.m. Eastern Time. A live audio,webcast of ... and will,be available by accessing DURECT,s homepage at ... to participate during the,live webcast, the call will be ...
... will receive milestones and ... by Altair - Altair to conduct clinical development ... FRANCISCO, Oct. 16 ,Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... Inc., a new venture,capital-funded biotechnology company, has been created to ...
Cached Biology Technology:Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition 2Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 2Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 3Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 4Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 5
(Date:10/2/2014)... 2014 CARTES ... identification and mobility which is being held at ... 6 November 2014, is proud to announce the ... agency FABERNOVEL.        (Logo: http://photos.prnewswire.com/prnh/20140526/689195) ... to support innovative businesses from the digital security ...
(Date:10/2/2014)... 2014 CARTES SECURE CONNEXIONS 2014 Conference: ... Sector CARTES SECURE CONNEXIONS 2014 is being held ... 6 November 2014. This 29 th  international meeting for ... mobility, will bring together the global community of a ... programme of conferences will set the pace for the ...
(Date:10/1/2014)... inheritance, showing for the first time that offspring can ... at least., This confronting idea, known as telegony, dates ... the early 20th Century with the advent of genetics., ... Crean, Professor Russell Bonduriansky and Dr Anna Kopps manipulated ... They found that the size of the young was ...
Breaking Biology News(10 mins):CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 2CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 3CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 4CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 5CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 2CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 3CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 4Semen secrets: How a previous sexual partner can influence another male's offspring 2
... multiple languages, cultures, races and religions, but among this diversity ... more united through our ears. In fact Mihailo Antovic, ... proposes that our musical conceptualization brings together a world of ... of distinct ethnic backgrounds and languages in his home of ...
... registration and abstract submission is now open at ... to be held in the Middle-East and Africa region. ... part of a new series of ,IOF Regionals, around ... energize research efforts in the region while offering advanced ...
... A drug already approved for people with cancer ... form of dementia, UT Southwestern Medical Center researchers report. ... a first-generation drug for the prevention and treatment of ... for which there is no treatment," said Dr. Joachim ...
Cached Biology News:1 world, 1 sound 21 world, 1 sound 3Cancer drug holds promise as first treatment for common, inherited dementia 2